COPD (Chronic Obstructive Pulmonary Disease) (cont.)
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
John P. Cunha, DO, FACOEP
John P. Cunha, DO, is a U.S. board-certified Emergency Medicine Physician. Dr. Cunha's educational background includes a BS in Biology from Rutgers, the State University of New Jersey, and a DO from the Kansas City University of Medicine and Biosciences in Kansas City, MO. He completed residency training in Emergency Medicine at Newark Beth Israel Medical Center in Newark, New Jersey.
In this Article
- COPD facts
- What is the definition of chronic obstructive pulmonary disease (COPD)?
- What causes COPD?
- What are the signs and symptoms of COPD?
- What increases your risk for developing COPD?
- What are the four stages of COPD?
- What other diseases or conditions contribute to COPD?
- What kind of doctor treats COPD?
- When to Seek Medical Care for COPD
- How is COPD diagnosed?
- What is the treatment for COPD?
- What lifestyle changes (diet, exercise) and home remedies and care are recommended for people with COPD?
- What medications treat COPD?
- What other supplemental therapies help treat COPD complications and symptoms?
- What surgery is available to treat COPD?
- Can COPD be prevented?
- What is the prognosis for a person with COPD?
- COPD (Chronic Obstructive Pulmonary Disease) FAQs
- Find a local Pulmonologist in your town
What are the four stages of COPD?
One way to stage COPD is the Global Initiative for Chronic Obstructive Lung Disease program (GOLD). The staging is based on the results of a pulmonary function test. Specifically, the forced expiratory volume (how much air one can exhale forcibly) in one second (FEV1) of a standard predicted value is measured, based on the individual patient's physical parameters. The staging of COPD by this method is as follows:
- Stage I is FEV1 of equal or more than 80% of the predicted value
- Stage II is FEV1 of 50% to 79% of the predicted value
- Stage III is FEV1 of 30% to 49% of the predicted value
- Stage IV is FEV1 of less than 30% of predicted value or an FEV1 less than 50% of predicted value plus respiratory failure
Other staging methods are similar but are based on the severity of the shortness of breath symptom that is sometimes subjective. The above staging is measurable objectively, providing the patient is putting forth their best effort.
What other diseases or conditions contribute to COPD?
In general, three other non-genetic problems related to the lung tissue play a role in COPD. 1) chronic bronchitis, 2) emphysema, and 3) infectious diseases of the lung.
- Chronic bronchitis and emphysema, are thought by many to be variations of COPD and considered part of the progression of COPD by many researchers. Chronic bronchitis is defined as a chronic cough that produces sputum for three or more months during two consecutive years.
- Emphysema is an abnormal and permanent enlargement of the air spaces (alveoli) located at the end of the terminal bronchioles in the lungs.
- Infectious diseases of the lung may damage areas of the lung tissue and contribute to COPD.
Find out what women really need.